Mutational analysis of PHEX, FGF23 and CLCN5 in patients with hypophosphataemic rickets
xmlui.dri2xhtml.METS-1.0.item-rights
info:eu-repo/semantics/closedAccessDate
2017Author
Guven, AylaAl-Rijjal, Roua A.
BinEssa, Huda A.
Dogan, Durmus
Kor, Yilmaz
Zou, Minjing
Kaya, Namik
Alenezi, Anwar F.
Hancili, Suna
Tarim, Omer
Baitei, Essa Y.
Kattan, Walaa E.
Meyer, Brian F.
Shi, Yufei
Metadata
Show full item recordAbstract
ContextHypophosphataemic rickets (HR) is a group of rare hereditary renal phosphate wasting disorders caused by mutations in PHEX, FGF23, DMP1, ENPP1, CLCN5 or SLC34A3. ObjectiveTo investigate underlying genetic defects in patients with hypophosphataemic rickets. MethodsWe analysed genomic DNA from nine unrelated families for mutations in the entire coding region of PHEX, FGF23, DMP1, ENPP1, CLCN5 or SLC34A3 by PCR sequencing and copy number analysis. ResultsA total of 14 patients were studied. PHEX mutations were identified in 12 patients from seven families. Five of them were novel mutations present in eight patients: c.154G>T (p.E52*), c.401_402insGCCAAA (p.Q134_K135insPK), c.1600C>T (p.P534S), g.22016715_22056805del (40-kb deletion including promoter and exons 1-3) and c.2242_2243delCT (p.L748fs*48). Four patients had previously reported mutations: c.1768+1G>A and c.1807G>A (p.W602*). Novel CLCN5 (c.1205G>A, p.W402*) and FGF23 (c.526C>G, p.R176G) mutations were found in two patients from the remaining two families. Many of the mutations were de novo: c.154G>T and c.2242_2243delCT in PHEX and c.526C>G in FGF23. Furthermore, we characterized the breakpoint of the novel PHEX g.22016715_22056805del and the c.2242_2243delCT, which is 6bp from the stop codon, resulting in a frameshift and extension of the reading frame by 42 amino acids. ConclusionsNovel and de novo mutations are frequent and PHEX mutations are still the most common genetic defects in the Turkish population. Gene copy number analysis should be considered in patients with negative results by conventional PCR-based sequencing analysis. The current study further expands the mutation spectrum underlying HR.